Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the ...

The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China. According to data from DealForma, as ...

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitches. The Indianapolis pharma has established an online portal to accept ...

Chang later returned home on the same road where hours earlier he’d hit Lilly Glaubach. He spent one more night with his wife and daughter before police knocked on his door after a Good ...

Top hedge funds such as Citadel and Millennium lost money in February, people familiar said. Geopolitical tensions brought on by President Donald Trump led to rocky markets last month. Some ...

There is currently no money to be made from things like wind and solar, a hedge fund set up specifically to profit from that niche has concluded. “The whole sector — solar, wind, hydrogen, ...

Aaron Brown is a former head of financial market research at AQR Capital Management. He is also an active crypto investor, and has venture capital investments and advisory ties with crypto firms.

To enquire about specific property features for 64 Lilly Pilly Court, Burpengary, contact the agent. What is the size of the property at 64 Lilly Pilly Court, Burpengary? The external land size ...

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Ackman's hedge fund, Pershing Square Capital, already owns about 37% of the company's outstanding shares. But everyday investors don't have to wait around for a complicated acquisition to go ...